Disparities in the management and outcome of cervical cancer in the United States according to health insurance status

Thomas Churilla, Brian Egleston, Yanqun Dong, Talha Shaikh, Colin Murphy, Gina Mantia-Smaldone, Christina Chu, Stephen Rubin, Penny Anderson

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Introduction Our study sought to characterize the presentation, local management and outcomes of invasive cervical cancer with regard to patient insurance status. Methods We queried the NCI-SEER database for invasive cervical cancer cases in patients aged 18–64 from 2007 to 2011. We analyzed clinical and socioeconomic data with regard insurance status (insured, Medicaid, or uninsured). We tested for associations between patient insurance status and treatment with definitive surgery for FIGO IA2-IB1 patients, and treatment with suboptimal radiation therapy (RT) for FIGO IB2-IVA patients (other than combination external beam and brachytherapy). We evaluated overall and cause specific survival according to insurance status. Results 11,714 cases were analyzed: 60% insured, 31% Medicaid, and 9% uninsured. FIGO III/IV stage at presentation was more frequent with Medicaid (40%) and uninsured (42%) compared to insured patients (28%) (p < 0.001). For FIGO IA2-IB1 patients, receipt of definitive surgery was inversely associated with uninsured status (OR [95%CI] = 0.65 [0.47–0.90], p < 0.001) in univariable analysis; however the relationship lost significance after multivariable adjustment. For FIGO IB2-IVA patients, the use of suboptimal RT was associated with uninsured status (OR [95%CI] = 1.33 [1.07–1.65], p = 0.011) in adjusted analyses. Among all patients, overall mortality was increased with Medicaid (HR [95%CI] = 1.16 [1.05–1.28], p = 0.003) and uninsured status (HR [95%CI] = 1.17 [1.01–1.34], p = 0.031) in multivariable analysis. Cancer specific mortality survival trended towards significance in multivariable analyses for both Medicaid (HR [95%CI] = 1.11 [1.00–1.24] and uninsured status (HR [95%CI] = 1.14 [0.98–1.33]). Conclusions Disparities in cervical cancer treatment with regard to insurance status are apparent in a recent cohort of American patients. Later stage at presentation and differences in management partially account for the inferior prognostic outcomes associated with Medicaid and uninsured status.

Original languageEnglish
Pages (from-to)516-523
Number of pages8
JournalGynecologic Oncology
Volume141
Issue number3
DOIs
StatePublished - Jun 2016

Fingerprint

Dive into the research topics of 'Disparities in the management and outcome of cervical cancer in the United States according to health insurance status'. Together they form a unique fingerprint.

Cite this